Fineline Cube

Follow:
14455 Articles
CompanyDeals

Luye Pharma Group Secures RMB 1.6 Billion Investment to Boost Financials and R&D

CompanyDrug

ICER Analysis Flags Pfizer’s ATTR-CM Therapy Vyndamax/Vyndaqel as Costly, Suggests Price Cut

R&D

Beijing Launches Bio-Park: A New Hub for International Pharmaceutical Innovation

CompanyDeals

MicroPort CardioFlow Secures Exclusive Distribution Rights for Evermend Occluders in China

Policy / Regulatory

China’s NMPA and NHC Implement New Rules for Temporary Import of Urgent Medical Devices

CompanyDeals

Jiangsu QYuns Therapeutics and Huadong Medicine Partner on QX005N Injection Development and Promotion

CompanyDrug

Innovent Biologics’ Mazdutide Achieves Primary and Secondary Endpoints in Phase III T2D Trial

Policy / Regulatory

China Unveils Ambitious Healthcare Reforms at 20th Central Committee Plenary Session

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval to Study CDK 4/6 Inhibitor Dalpiciclib in Combination with HRS-1358 for Breast Cancer

CompanyDrug

Hansoh Pharmaceutical’s EGFR Inhibitor Ameile Files for Adjuvant Therapy Approval with NMPA

CompanyDrug

NMPA Approves Chengdu Chipscreen’s Bilessglu for Type 2 Diabetes in Combination with Metformin

CompanyDeals

Eisai Forges Partnerships with Chinese Firms to Strengthen Alzheimer’s Disease Market Presence